Program at a Glance
- 현재 페이지 경로
> Program > Program at a Glance
- Scientific Session [Boehringer Ingelheim/Lilly]
- SGLT2 Inhibition in HFrEF; Digging Deeper and Treating Earlier
- Apr. 15 (Fri.) 13:10-13:50, Rm.103
- Chairpersons: Myeong Ki Hong, Byung Su Yoo
-
13:10 - 13:30
-
Quantum Leaps with Empagliflozin from T2D to HFrEF
[Speaker] Jon Suh / Soonchunhyang Univ., Korea
-
13:30 - 13:50
-
Empagliflozin as An Early, First Line Therapy in Patients with HFrEF
[Speaker] Jae Yeong Cho / Chonnam National Univ., Korea
- The Korean Society of Cardiology
-
101-1704, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul, 04146, Republic of Korea
Copyright© The Korean Society of Cardiology. All rights reserved.
